Gene Expression Analysis of Immunomagnetically Enriched Circulating Tumor Cell Fraction in Castration-Resistant Prostate Cancer

被引：0
|
作者：
Markéta Škereňová
Veronika Mikulová
Otakar Čapoun
David Švec
Katarína Kološtová
Viktor Soukup
Hana Honová
Tomáš Hanuš
Tomáš Zima
机构：
[1] Charles University in Prague,Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine
[2] Charles University in Prague,Department of Urology, General University Hospital and First Faculty of Medicine
[3] Institute of Biotechnology CAS,Laboratory of Gene Expression
[4] Charles University in Prague,Institute of Laboratory Diagnostics, Third Faculty of Medicine
[5] Charles University in Prague,Department of Oncology, General University Hospital in Prague and First Faculty of Medicine
[6] Laboratory of Immunology and Allergology,undefined
来源：
Molecular Diagnosis & Therapy | 2018年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：381 / 390
页数：9
相关论文
共 50 条
  • [41] Analysis of androgen receptor dynamics through immunofluorescent staining of circulating tumor cells in castration-resistant prostate cancer
    Barnett, Ethan
    Gupta, Santosh
    Erazo, Tatiana
    Carbone, Ernest Lam Emily
    Zanone, Michelle
    Nystrom, Lucy
    Gajar, Ria N.
    Wenstrup, Rick
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] CIRCULATING MICRORNAS ASSOCIATED WITH DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER
    Mahon, K. L.
    Chiam, K.
    Lee, B. Y.
    Nguyen, Q.
    Boyer, M. J.
    Stockler, M.
    Pavlakis, N.
    Marx, G.
    Mallesara, G.
    Gurney, H.
    Clark, S.
    Swarbrick, A.
    Daly, R.
    Horvath, Lisa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 26 - 27
  • [43] Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
    Attard, Gerhardt
    Swermenhuis, Joost F.
    Olmos, David
    Reid, Alison H. M.
    Vickers, Elaine
    A'Hern, Roger
    Levink, Rianne
    Coumans, Frank
    Moreira, Joana
    Riisnaes, Ruth
    Oommen, Nikhil Babu
    Hawche, George
    Jameson, Charles
    Thompson, Emilda
    Sipkema, Ronald
    Carden, Craig P.
    Parker, Christopher
    Dearnaley, David
    Kaye, Stan B.
    Cooper, Colin S.
    Molina, Arturo
    Cox, Michael E.
    Terstappen, Leon W. M. M.
    de Bono, Johann S.
    CANCER RESEARCH, 2009, 69 (07) : 2912 - 2918
  • [44] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Pleskow, H.
    Otani, K.
    Kusaka, E.
    Ukleja, J.
    Balza, R.
    Fisher, R.
    Broderick, K.
    Maheswaran, S.
    Haber, D.
    Saylor, P. J.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
  • [45] Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer
    Wang, Jasmine J.
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Cook-Wiens, Galen
    Yao, Nu
    Chu, Gina C.
    Chen, Pin-Jung
    Yang, Yingying
    Yeo, Yee Hui
    Lee, Yi-Te
    Chung, Leland W.
    You, Sungyong
    Zhu, Yazhen
    Freeman, Michael R.
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin M.
    CANCER RESEARCH, 2020, 80 (16)
  • [46] Epithelial-to-mesenchymal markers of circulating tumor cells for detection of castration-resistant prostate cancer
    Chen, Chun-Liang
    Osmulski, Pawel
    Mahalingam, Devalingam
    Horning, Aaron M.
    Jadhav, Rohit R.
    Louie, Anna D.
    Wang, Chiou-Miin
    Huang, Tim H. -M.
    CANCER RESEARCH, 2014, 74 (19)
  • [47] CD133 expression in circulating tumor cells (CTCs) from metastatic castration-resistant prostate cancer (mCRPC).
    Ana Marcos, Rosa
    Alfonso, Sara
    Lozano, Rebeca
    Matos, Ignacio
    Espinet, Blanca
    Garcia, Rocio
    Maria Hernandez, Jesus
    Gomez-Veiga, Francisco
    Luis Hernandez, Juan
    Cruz, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Circulating Tumor Cell Eradication as an Intermediate Efficacy End Point for Metastatic Castration-Resistant Prostate Cancer: Is There Enough Evidence?
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 525 - +
  • [49] Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
    Scher, Howard I.
    Heller, Glenn
    Molina, Arturo
    Attard, Gerhardt
    Danila, Daniel C.
    Jia, Xiaoyu
    Peng, Weimin
    Sandhu, Shahneen K.
    Olmos, David
    Riisnaes, Ruth
    McCormack, Robert
    Burzykowski, Tomasz
    Kheoh, Thian
    Fleisher, Martin
    Buyse, Marc
    de Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) : 1348 - +
  • [50] Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer
    Wang, Jasmine Jiemei
    Teng, Pai-Chi
    Jan, Yu Jen
    Chen, Jie-Fu
    Cook-Wiens, Galen
    Yao, Nu
    Chu, Gina Chia-Yi
    Chen, Pin-Jung
    Ho, Hao
    Yang, Yingying
    Lee, Yi-Te
    Huang, Jiaoti
    Chung, Leland W. K.
    You, Sungyong
    Zhu, Yazhen
    Freeman, Michael
    Rogatko, Andre
    Yang, Ju Dong
    Tseng, Hsian-Rong
    Posadas, Edwin M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345